The new Cytiva is here! I'm excited to share Emmanuel Ligner's thoughts about it! Read the full announcement. ms.spr.ly/6016gTet2 #WeAreCytiva #BetterTogether #biopharma

Cytiva experts Scott Ripley, PhD, and Tracy Humphries discuss how RNA therapeutics will impact the development of genomic medicines. ms.spr.ly/6018gp9Ej #RNA #WeAreCytiva

Emmanuel Ligner, President and CEO of Cytiva and Danaher Group Executive, discusses the impact of the merger on the biopharma industry in the APAC region and the benefits for customers and stakeholders with BioPharma APAC. ms.spr.ly/6013gnxXN

Emmanuel Ligner, President and CEO of Cytiva and Danaher Group Executive, discusses the impact of the merger on the biopharma industry in the APAC region and the benefits for customers and stakeholders with BioPharma APAC. ms.spr.ly/6010gX924

Learn how our integration with the life sciences business of Pall combines broad expertise, deep talent, and exceptional service to help the #biopharma industry realize the potential of #genomicmedicine. ms.spr.ly/6017gZikD #WeAreCytiva #BetterTogether

Derek O'Sullivan, VP of Human Resources, is optimistic about the future of the new Cytiva. ms.spr.ly/6012gbO9s #WeAreCytiva #BetterTogether

I'm attending Key findings from the 2023 Global Biopharma Resilience Index. Would you like to attend? lnkd.in/gCzAtVab

It's the state of the industry. Read Cytiva's Biopharma Resilience Index findings here: ms.spr.ly/6011gin1h

Why build a team around nucleic acid therapeutics? Stay tuned to learn the answer. #nucleicacidtherapeutics #mRNA #oligos #nucleicacids

Research indicates that only 26% of people often leave the office having accomplished the tasks they set out to do. A good first step is understanding the mental mistakes that typically prevent us from focusing on and finishing meaningful work. hbr.org/2019/11/5-ment…

Leadership is more of an attitude than a job title. Here's how you can be seen as a leader, regardless of your role. forbes.com/sites/williama…

Korean healthcare media Hit News deep-dives into what Fast Trak provides to train bioprocess professionals in APAC region. #wearecytiva hitnews.co.kr/news/articleVi…

In this interview with BioPharma BoardRoom, Keng Hock Chua, Commercial General Manager, Bioprocess, Asia Pacific, Cytiva, digs deep into the root causes and offers potential solutions to improve the biopharma industry's resilience. linkedin.com/posts/biopharm…

Cytiva has launched the NanoAssemblr commercial formulation system, purpose-built for clinical and commercial manufacturing of lipid nanoparticle medicines. Read the full story from Tech Networks: technologynetworks.com/biopharma/prod… #lipidnanoparticles #genetherapy #cellandgenetherapy

💡 Gain valuable insights into the evolving landscape of the biotech industry. Explore the factors influencing the industry's overall resilience score, which dipped from 6.60 to 6.08. Download the report from cytivalifesciences.com/en/se/behind-b…

Check out this article to learn how Cytiva is supporting APAC Biotechs as they scale up - helping to accelerate development of innovative therapies for patients! genengnews.com/insights/how-s… #biotech #innovation #patientaccess

Some combinations just deliver. That's why Pall Life Sciences and Cytiva are uniting to build a better future for biopharma. Learn more: cytiva.link/pairingvidlie #WeAreCytiva #BetterTogether #biopharma #lifesciences

#NewProfilePic

Season to success. Don't mess with a recipe that works. Pall Life Sciences and Cytiva are now together to better serve biopharma. Learn more: cytiva.link/season2success… #WeAreCytiva #BetterTogether #biopharma #lifesciences

We're into 2024 with a new CEO, Chris Riley. Dan Stanton is first out with an interview, where Chris shares some early thoughts about leading Cytiva into our next phase. cytiva.link/je0gw